PerkinElmer Genomics has a long history of screening and identifying patients with rare diseases. Since our founding in 1994, we have screened more than 70 million newborns. We help save the lives of thousands of babies every year.
Leveraging PerkinElmer’s position as an industry-leader in workflow solutions and genetic expertise, we create unmatched efficiency, quality, and sustainability within the lab. These capabilities enable us to accelerate our report delivery and increase affordability empowering clinicians and researchers to utilize genetic testing earlier in the diagnostic process.
With a network of laboratories in the USA, China, and India, PerkinElmer Genomics can support research and testing collaborations around the globe. Our collaborators can access capabilities such as:
PerkinElmer Genomics has extensive experience in genomics via our team of certified Biochemical Genetics, Cytogenetics and Molecular Genetics experts.
PerkinElmer Genomics offers a wide array of services to pharmaceutical companies and researchers who are in need of screening patients for genetic diseases. We enable research and testing service programs to deploy globally through our network of labs and our enhanced access to testing.